US 12258317
Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
granted A61KA61K31/472A61K31/517
Quick answer
US patent 12258317 (Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/472, A61K31/517, A61P, A61P1/16